Enabling Cape Verde to Perform Total Hip Replacement: Cost-Benefit Study
DOI:
https://doi.org/10.20344/amp.10405Keywords:
Arthroplasty, Replacement, Hip/economics, Cabo Verde, Cost-Benefit Analysis, Quality of Health CareAbstract
Introduction: Cape Verde is a middle-income country benefiting from a health agreement with Portugal. The purpose of this study is to conduct a cost-benefit analysis on the enablement of Cape Verde to perform total hip replacement.
Material and Methods: We assessed records from the Orthopaedic Department of Baptista de Sousa Hospital and the Portuguese Directorate-General of Health regarding hip fracture with indication for total hip replacement and hip arthritis cases evacuated to Portugal. We also analysed the direct costs of the treatment, and hypothesised the costs of performing total hip replacement in Cape Verde. We then conducted a cost-benefit analysis.
Results: From 2011 to 2016, 126 patients (135 hips) would have indication for total hip replacement if it was possible to do it in Cape Verde. The performance of the procedure in Cape Verde would have resulted in a global benefit of €80 644.08, and a benefit of €597.36/per patient.
Discussion: Our analysis indicates that the enablement of Cape Verde to autonomously perform total hip replacement on patients with hip fracture and arthritis would have a positive financial return. Total costs were underestimated due to the impossibility to calculate indirect costs. Enabling Cape Verde to perform total hip replacement would provide the recommended treatment for patients and reduce the socio-psychological impact of evacuation.
Conclusion: Enabling Cape Verde to perform total hip replacement would represent an expense reduction, and an improvement of the country’s quality of healthcare and autonomy.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.
